Skip to content

CRNXCRINETICS PHARMACEUTICALS IN

CUSIP 22663K107 · common stock

No tracked investor reported shares of CRINETICS PHARMACEUTICALS IN (CRNX) for Q3 2026. 3 investors sold out this quarter, including Julian Baker.

Holders · Q3 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—

Investors holding CRNX · Q3 2026

No tracked investor reported shares this quarter.

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Julian Baker0.44%2,351,465$88MEXIT
Adar1 Capital Management2.09%1,222,080$45.7MEXIT
Ken Fisher0.01%741,553$27.7MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026003$0—
Q2 2026300$161.5M$37.42
Q1 2026300$154.5M$36.32
Q4 2025300$126.5M$46.55